Found: 34
Select item for more details and to access through your institution.
Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. e613, doi. 10.1210/clinem/dgad061
- By:
- Publication type:
- Article
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. 2195, doi. 10.1210/clinem/dgac325
- By:
- Publication type:
- Article
Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. e3420, doi. 10.1210/clinem/dgac222
- By:
- Publication type:
- Article
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 10, p. e4072, doi. 10.1210/clinem/dgab396
- By:
- Publication type:
- Article
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion.
- Published in:
- Case Reports in Endocrinology, 2020, p. 1, doi. 10.1155/2020/4147097
- By:
- Publication type:
- Article
Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 9, p. 3603, doi. 10.1210/jc.2006-1006
- By:
- Publication type:
- Article
Treatment with Drugs Able to Reduce Iodine Efflux Significantly Increases the Intracellular Retention Time in Thyroid Cancer Cells Stably Transfected with Sodium Iodide Symporter Complementary Deoxyribonucleic Acid.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 6, p. 2389, doi. 10.1210/jc.2005-2480
- By:
- Publication type:
- Article
Dose-Dependent Generation of RET/PTC in Human Thyroid Cells after in Vitro Exposure to γ-Radiation: A Model of Carcinogenic Chromosomal Rearrangement Induced by Ionizing Radiation.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 4, p. 2364, doi. 10.1210/jc.2004-1811
- By:
- Publication type:
- Article
All-Trans-Retinoic Acid Treatment Inhibits the Growth of Retinoic Acid Receptor β Messenger Ribonucleic Acid Expressing Thyroid Cancer Cell Lines but Does Not Reinduce the Expression of Thyroid-Specific Genes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 4, p. 2403, doi. 10.1210/jc.2004-0969
- By:
- Publication type:
- Article
Identification of a Novel Point Mutation in the RET Gene (Ala883Thr), Which Is Associated with Medullary Thyroid Carcinoma Phenotype Only in Homozygous Condition.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 11, p. 5823, doi. 10.1210/jc.2004-0312
- By:
- Publication type:
- Article
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1667, doi. 10.1007/s00262-020-02810-6
- By:
- Publication type:
- Article
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 6970, doi. 10.3390/jcm12226970
- By:
- Publication type:
- Article
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00522-4
- By:
- Publication type:
- Article
Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 10, p. 1542, doi. 10.3390/biom11101542
- By:
- Publication type:
- Article
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
- Published in:
- Oncogene, 2005, v. 24, n. 44, p. 6646, doi. 10.1038/sj.onc.1208822
- By:
- Publication type:
- Article
Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.
- Published in:
- Thyroid, 2020, v. 30, n. 11, p. 1579, doi. 10.1089/thy.2019.0352
- By:
- Publication type:
- Article
Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5554, doi. 10.3390/cancers13215554
- By:
- Publication type:
- Article
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3200, doi. 10.3390/cancers13133200
- By:
- Publication type:
- Article
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 94, doi. 10.3390/cancers13010094
- By:
- Publication type:
- Article
NF1 gene inactivation acts as a tumor driver in RET/RAS-negative medullary thyroid carcinomas.
- Published in:
- European Journal of Endocrinology, 2023, v. 188, n. 5, p. 430, doi. 10.1093/ejendo/lvad051
- By:
- Publication type:
- Article
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
- Published in:
- European Journal of Endocrinology, 2015, v. 173, n. 3, p. 297, doi. 10.1530/EJE-15-0304
- By:
- Publication type:
- Article
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.
- Published in:
- Endocrine (1355008X), 2019, v. 65, n. 3, p. 623, doi. 10.1007/s12020-019-01957-2
- By:
- Publication type:
- Article
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series.
- Published in:
- Thyroid, 2013, v. 23, n. 1, p. 50, doi. 10.1089/thy.2012.0207
- By:
- Publication type:
- Article
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer.
- Published in:
- Thyroid, 2012, v. 22, n. 5, p. 476, doi. 10.1089/thy.2011.0358
- By:
- Publication type:
- Article
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 9174, doi. 10.3892/ol.2018.8470
- By:
- Publication type:
- Article
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency.
- Published in:
- Genes, 2021, v. 12, n. 1, p. 35, doi. 10.3390/genes12010035
- By:
- Publication type:
- Article
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations.
- Published in:
- Genes, 2019, v. 10, n. 9, p. 698, doi. 10.3390/genes10090698
- By:
- Publication type:
- Article
Alterations of the BRAF gene in thyroid tumors.
- Published in:
- Endocrine Pathology, 2005, v. 16, n. 3, p. 163, doi. 10.1385/EP:16:3:163
- By:
- Publication type:
- Article
BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization.
- Published in:
- Endocrine Pathology, 2005, v. 16, n. 2, p. 99, doi. 10.1385/EP:16:2:099
- By:
- Publication type:
- Article
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01390
- By:
- Publication type:
- Article
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
- Published in:
- Clinical Endocrinology, 2015, v. 82, n. 6, p. 892, doi. 10.1111/cen.12686
- By:
- Publication type:
- Article